These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 35571640)
1. Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review. König F; Pradere B; Grossmann NC; Quhal F; Rajwa P; Laukhtina E; Mori K; Katayama S; Yanagisawa T; Mostafai H; Motlagh RS; Aydh A; Dahlem R; Shariat SF; Rink M Transl Cancer Res; 2022 Apr; 11(4):908-917. PubMed ID: 35571640 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients. Hamid ARAH; Ridwan FR; Parikesit D; Widia F; Mochtar CA; Umbas R BMC Urol; 2020 Oct; 20(1):158. PubMed ID: 33054762 [TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant and adjuvant treatments in muscle-invasive bladder cancer: Where are we? Osanto S; Álvarez Gómez de Segura C Arch Esp Urol; 2020 Dec; 73(10):971-985. PubMed ID: 33269716 [TBL] [Abstract][Full Text] [Related]
4. Quality Indicators for Bladder Cancer Services: A Collaborative Review. Leow JJ; Catto JWF; Efstathiou JA; Gore JL; Hussein AA; Shariat SF; Smith AB; Weizer AZ; Wirth M; Witjes JA; Trinh QD Eur Urol; 2020 Jul; 78(1):43-59. PubMed ID: 31563501 [TBL] [Abstract][Full Text] [Related]
5. Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre experience. Boeri L; Soligo M; Frank I; Boorjian SA; Thompson RH; Tollefson M; Quevedo FJ; Cheville JC; Karnes RJ BJU Int; 2019 Jun; 123(6):1011-1019. PubMed ID: 30623554 [TBL] [Abstract][Full Text] [Related]
6. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients. Koga F; Kihara K; Yoshida S; Yokoyama M; Saito K; Masuda H; Fujii Y; Kawakami S BJU Int; 2012 Mar; 109(6):860-6. PubMed ID: 21854531 [TBL] [Abstract][Full Text] [Related]
7. The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study. Gandaglia G; Popa I; Abdollah F; Schiffmann J; Shariat SF; Briganti A; Montorsi F; Trinh QD; Karakiewicz PI; Sun M Eur Urol; 2014 Sep; 66(3):561-8. PubMed ID: 24486024 [TBL] [Abstract][Full Text] [Related]
8. Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study. Grossmann NC; Rajwa P; Quhal F; König F; Mostafaei H; Laukhtina E; Mori K; Katayama S; Motlagh RS; Fankhauser CD; Mattei A; Moschini M; Chlosta P; van Rhijn BWG; Teoh JYC; Compérat E; Babjuk M; Abufaraj M; Karakiewicz PI; Shariat SF; Pradere B Eur Urol Open Sci; 2022 May; 39():14-21. PubMed ID: 35528782 [TBL] [Abstract][Full Text] [Related]
9. Impact of sarcopenia in bladder preservation therapy for muscle-invasive bladder cancer patients: a narrative review. Fukushima H; Koga F Transl Androl Urol; 2022 Oct; 11(10):1433-1441. PubMed ID: 36386266 [TBL] [Abstract][Full Text] [Related]
11. The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. Bruins HM; Veskimae E; Hernandez V; Imamura M; Neuberger MM; Dahm P; Stewart F; Lam TB; N'Dow J; van der Heijden AG; Compérat E; Cowan NC; De Santis M; Gakis G; Lebret T; Ribal MJ; Sherif A; Witjes JA Eur Urol; 2014 Dec; 66(6):1065-77. PubMed ID: 25074764 [TBL] [Abstract][Full Text] [Related]
12. Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans. Kumar A; Cherry DR; Courtney PT; Nalawade V; Kotha N; Riviere PJ; Efstathiou J; McKay RR; Karim Kader A; Rose BS; Stewart TF Eur Urol Open Sci; 2021 Aug; 30():1-10. PubMed ID: 34337540 [TBL] [Abstract][Full Text] [Related]
13. The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer. Koie T; Ohyama C; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Yamauchi A; Shimazui T; Ohtani M Jpn J Clin Oncol; 2017 Mar; 47(3):252-256. PubMed ID: 27980085 [TBL] [Abstract][Full Text] [Related]
14. Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. Bree KK; Hensley PJ; Westerman ME; Kokorovic A; Nogueras-Gonzalez GM; Dinney CP; Kamat AM; Navai N J Urol; 2021 Sep; 206(3):577-585. PubMed ID: 33872050 [TBL] [Abstract][Full Text] [Related]
15. The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer. Hadjizacharia P; Stein JP; Cai J; Miranda G World J Urol; 2009 Feb; 27(1):33-8. PubMed ID: 19020884 [TBL] [Abstract][Full Text] [Related]
16. Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial. Briganti A; Gandaglia G; Scuderi S; Gallina A; Colombo R; Fossati N; Barletta F; Pellegrino A; Nocera L; Montorsi F; Necchi A Eur Urol; 2020 May; 77(5):576-580. PubMed ID: 31911010 [TBL] [Abstract][Full Text] [Related]
17. Increased One-Year Mortality Among Elderly Patients After Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective, Observational Comparative Study. Lemiński A; Kaczmarek K; Gołąb A; Kotfis K; Skonieczna-Żydecka K; Słojewski M Clin Interv Aging; 2022; 17():255-263. PubMed ID: 35299721 [TBL] [Abstract][Full Text] [Related]
18. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Gakis G; Efstathiou J; Lerner SP; Cookson MS; Keegan KA; Guru KA; Shipley WU; Heidenreich A; Schoenberg MP; Sagaloswky AI; Soloway MS; Stenzl A; Eur Urol; 2013 Jan; 63(1):45-57. PubMed ID: 22917985 [TBL] [Abstract][Full Text] [Related]
19. Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial. Hinsenveld FJ; Noordman BJ; Boormans JL; Voortman J; van Leenders GJLH; van der Pas SL; van Beek SC; Oprea-Lager DE; Vis AN BMC Cancer; 2021 Oct; 21(1):1161. PubMed ID: 34715822 [TBL] [Abstract][Full Text] [Related]
20. Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy. Hensley PJ; Bree KK; Campbell MT; Alhalabi O; Kokorovic A; Miest T; Nogueras-Gonzalez GM; Gao J; Siefker-Radtke AO; Guo CC; Navai N; Dinney CP; Kamat AM J Urol; 2021 Nov; 206(5):1258-1267. PubMed ID: 34184926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]